Cargando…

Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection

OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhao, Zhang, Yepeng, Liu, Chen, Huang, Dian, Zhang, Ming, Ran, Feng, Wang, Wei, Shang, Tao, Qiao, Tong, Zhou, Min, Liu, Changjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718725/
https://www.ncbi.nlm.nih.gov/pubmed/28701057
http://dx.doi.org/10.1177/0300060517708893
_version_ 1783284370839175168
author Liu, Zhao
Zhang, Yepeng
Liu, Chen
Huang, Dian
Zhang, Ming
Ran, Feng
Wang, Wei
Shang, Tao
Qiao, Tong
Zhou, Min
Liu, Changjian
author_facet Liu, Zhao
Zhang, Yepeng
Liu, Chen
Huang, Dian
Zhang, Ming
Ran, Feng
Wang, Wei
Shang, Tao
Qiao, Tong
Zhou, Min
Liu, Changjian
author_sort Liu, Zhao
collection PubMed
description OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B aortic dissection. RESULTS: Complications included endoleak, distal true lumen collapse, retrograde dissection, stroke, stent–graft (SG) migration and mistaken deployment, lower limb ischaemia, and SG fracture. Treatment included endovascular repair, surgical procedures, or conservative medication. Forty-six patients recovered from complications. Twelve patients were not cured. The median follow-up time was 29.5 months (2–61 months). The overall 30-day mortality rate was 1.7% (1/58) and the total mortality rate following secondary complications was 8.6% (5/58). The causes of death were stroke and aortic rupture. CONCLUSION: Some treatments need to be performed after TEVAR because of severe complications. A reduction in these complications can be achieved by optimal evaluation of patients, selection of SGs, and specialized endovascular manipulation.
format Online
Article
Text
id pubmed-5718725
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57187252017-12-11 Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection Liu, Zhao Zhang, Yepeng Liu, Chen Huang, Dian Zhang, Ming Ran, Feng Wang, Wei Shang, Tao Qiao, Tong Zhou, Min Liu, Changjian J Int Med Res Clinical Reports OBJECTIVE: This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. METHODS: From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B aortic dissection. RESULTS: Complications included endoleak, distal true lumen collapse, retrograde dissection, stroke, stent–graft (SG) migration and mistaken deployment, lower limb ischaemia, and SG fracture. Treatment included endovascular repair, surgical procedures, or conservative medication. Forty-six patients recovered from complications. Twelve patients were not cured. The median follow-up time was 29.5 months (2–61 months). The overall 30-day mortality rate was 1.7% (1/58) and the total mortality rate following secondary complications was 8.6% (5/58). The causes of death were stroke and aortic rupture. CONCLUSION: Some treatments need to be performed after TEVAR because of severe complications. A reduction in these complications can be achieved by optimal evaluation of patients, selection of SGs, and specialized endovascular manipulation. SAGE Publications 2017-07-12 2017-10 /pmc/articles/PMC5718725/ /pubmed/28701057 http://dx.doi.org/10.1177/0300060517708893 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Reports
Liu, Zhao
Zhang, Yepeng
Liu, Chen
Huang, Dian
Zhang, Ming
Ran, Feng
Wang, Wei
Shang, Tao
Qiao, Tong
Zhou, Min
Liu, Changjian
Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title_full Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title_fullStr Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title_full_unstemmed Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title_short Treatment of serious complications following endovascular aortic repair for type B thoracic aortic dissection
title_sort treatment of serious complications following endovascular aortic repair for type b thoracic aortic dissection
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718725/
https://www.ncbi.nlm.nih.gov/pubmed/28701057
http://dx.doi.org/10.1177/0300060517708893
work_keys_str_mv AT liuzhao treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT zhangyepeng treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT liuchen treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT huangdian treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT zhangming treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT ranfeng treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT wangwei treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT shangtao treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT qiaotong treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT zhoumin treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection
AT liuchangjian treatmentofseriouscomplicationsfollowingendovascularaorticrepairfortypebthoracicaorticdissection